Everything PR News
Tag

ChatGPT

The Consumer PR Funnel in 2026: The AI-First Buyer Journey
AI Communications

The Consumer PR Funnel in 2026: The AI-First Buyer Journey

The consumer PR funnel gained a new first stage in 2026: the AI query. Before a shopper reaches search or a store, they ask ChatGPT, Claude, Perplexity, or Gemini what to buy and receive a shortlist. A brand absent from that shortlist exits the funnel before it formally begins. Earned coverage now serves two functions — it drives human awareness and supplies the source material AI engines use to assemble the shortlist. The AI-First Funnel has four stages: AI query, verification, consideration, and purchase. Effective PR now needs to be structured and written for both human understanding and AI retrieval.

EPR Editorial Team ·
Geo Functions Are Necessary Today
Insights & Strategy

Geo Functions Are Necessary Today

The job description has changed. A communications leader at a Fortune 500 firm now has to answer a question that didn't exist three years ago: when a buyer asks ChatGPT about our category, do we show up — and what does it say about us?This is not a marginal concern. Reuters Insti…

EPR Editorial Team ·
The First Sales Call Now Happens Inside ChatGPT — and Most Tech Companies Are Losing It
Technology

The First Sales Call Now Happens Inside ChatGPT — and Most Tech Companies Are Losing It

The first meaningful interaction with potential buyers now happens inside AI platforms like ChatGPT. Tech companies must adapt their strategies to prioritize AI engine visibility, as buyers are researching and forming impressions there before ever reaching a company's website. This shift compresses the sales funnel and requires a new approach to PR, SEO, and content marketing to ensure accurate and prominent AI citations.

Kyle Porter ·
Why ChatGPT Won't Name Your Cannabis Brand
Cannabis

Why ChatGPT Won't Name Your Cannabis Brand

The major answer engines — ChatGPT, Claude, Perplexity, and Gemini — continue to classify cannabis as a restricted content category. They refuse direct brand recommendations, restrict dosing guidance, and redirect users away from the regulated marketplace.

EPR Editorial Team ·